Skip to main content
Top
Published in: Archives of Orthopaedic and Trauma Surgery 12/2011

01-12-2011 | Orthopaedic Outcome Assessment

Intra-articular injection of hyaluronic acid (MW 1,500–2,000 kDa; HyalOne®) in symptomatic osteoarthritis of the hip: a prospective cohort study

Authors: Migliore Alberto, Massafra Umberto, Bizzi Emanuele, Laganà Bruno, Germano Valentina, Piscitelli Prisco, Granata Mauro, Tormenta Sandro

Published in: Archives of Orthopaedic and Trauma Surgery | Issue 12/2011

Login to get access

Abstract

Introduction

Clinical trials have demonstrated the safety and efficacy of hyaluronic acid-based products for the treatment of hip osteoarthritis, but data from observational studies of normal medical practice are scarce. This study investigated the long-term efficacy and tolerability of ultrasound-guided intra-articular sodium hyaluronate (MW 1,500–2,000 kDa; Hyalone®) injections in daily clinical practice.

Methods

In this observational, cohort study of patients with hip osteoarthritis, Hyalone® was administered under the ultrasound guidance, every 6 months, with the possibility of an additional injection at the intervening 3-month intervals on clinical request. Efficacy measurements included the Lequesne algofunctional index, self-reported pain via the visual analogue scale (VAS), the concomitant use of non-steroidal anti-inflammatory drugs (NSAIDs) and safety. The patients were followed up for 18 months after the first intra-articular injection.

Results

Data from 120 patients were collected. During the study, a statistically significant reduction in algofunctional indexes was demonstrated at 3 months after study product injection, while at 12 months 80% of the patients achieved a decrease of at least 30% in symptoms. These results were maintained over time through cyclical and personalized repetition of ultrasound guided injections, at least one injection every 6 months.

Conclusions

The study treatment reduced pain and improved mobility in osteoarthritis of the hip. These results in daily clinical practice demonstrate a beneficial effect and the safety of the study product and suggest adding intra-articular injections of HyalOne® to the armamentarium of conservative management of symptomatic hip osteoarthritis.
Literature
1.
go back to reference Symmons D, Mathers C, Pfleger B (2003) Global burden of osteoarthritis in the year 2000. World Health Organization, Geneva Symmons D, Mathers C, Pfleger B (2003) Global burden of osteoarthritis in the year 2000. World Health Organization, Geneva
2.
go back to reference Altman RD (2003) Status of hyaluronan supplementation therapy in osteoarthritis. Curr Rheumatol Rep 5(1):7–14PubMedCrossRef Altman RD (2003) Status of hyaluronan supplementation therapy in osteoarthritis. Curr Rheumatol Rep 5(1):7–14PubMedCrossRef
3.
go back to reference Lo GH, LaValley M, McAlindon T, Felson DT (2003) Intra-articular hyaluronic acid in treatment of knee osteoarthritis: a meta-analysis. JAMA 290:3115–3121PubMedCrossRef Lo GH, LaValley M, McAlindon T, Felson DT (2003) Intra-articular hyaluronic acid in treatment of knee osteoarthritis: a meta-analysis. JAMA 290:3115–3121PubMedCrossRef
4.
go back to reference Arrich J, Piribauer F, Mad P et al (2005) Intra-articular hyaluronic acid for the treatment of osteoarthritis of the knee: systematic review and meta-analysis. CMAJ 172:1039–1043PubMedCrossRef Arrich J, Piribauer F, Mad P et al (2005) Intra-articular hyaluronic acid for the treatment of osteoarthritis of the knee: systematic review and meta-analysis. CMAJ 172:1039–1043PubMedCrossRef
5.
go back to reference Wang C-T, Lin J, Chang C-J et al (2004) Therapeutic effects of hyaluronic acid on osteoarthritis of the knee. JBJS 86A(3):538–545 Wang C-T, Lin J, Chang C-J et al (2004) Therapeutic effects of hyaluronic acid on osteoarthritis of the knee. JBJS 86A(3):538–545
6.
go back to reference Bellamy N, Campbell J, Robinson V et al (2006) Viscosupplementation for the treatment of osteoarthritis of the knee. Cochrane Database Syst Rev 2:CD005321PubMed Bellamy N, Campbell J, Robinson V et al (2006) Viscosupplementation for the treatment of osteoarthritis of the knee. Cochrane Database Syst Rev 2:CD005321PubMed
7.
go back to reference Aggarwal A, Sempowski IP (2004) Hyaluronic acid injections for knee osteoarthritis. Systematic review of the literature. Can Fam Physician 50:249–256PubMed Aggarwal A, Sempowski IP (2004) Hyaluronic acid injections for knee osteoarthritis. Systematic review of the literature. Can Fam Physician 50:249–256PubMed
8.
go back to reference Kolarz G, Kotz R, Hochmayer I (2003) Long-term benefits and repeated treatment cycles of intra-articular sodium hyaluronate (Hyalgan) in patients with osteoarthritis of the knee. Semin Arthritis Rheum 32(5):310–319PubMedCrossRef Kolarz G, Kotz R, Hochmayer I (2003) Long-term benefits and repeated treatment cycles of intra-articular sodium hyaluronate (Hyalgan) in patients with osteoarthritis of the knee. Semin Arthritis Rheum 32(5):310–319PubMedCrossRef
9.
go back to reference Brzusek D, Petron D (2008) Treating knee osteoarthritis with intra-articular hyaluronans. Curr Med Res Opin 24(12):3307–3322PubMedCrossRef Brzusek D, Petron D (2008) Treating knee osteoarthritis with intra-articular hyaluronans. Curr Med Res Opin 24(12):3307–3322PubMedCrossRef
10.
go back to reference Schieb F (2003) Intraartikulär injizierte Hyaluronsäure bei Arthropathien. Arthritis rheum 23(6):338–340 Schieb F (2003) Intraartikulär injizierte Hyaluronsäure bei Arthropathien. Arthritis rheum 23(6):338–340
11.
go back to reference Foti C, Cisari C, Carda S, Giordan N, Rocco A, Frizziero A, Della Bella G (2011) A prospective observational study of the clinical efficacy and safety of intra-articular sodium hyaluronate in synovial joints with osteoarthritis. Eur J Phys Rehabil Med Foti C, Cisari C, Carda S, Giordan N, Rocco A, Frizziero A, Della Bella G (2011) A prospective observational study of the clinical efficacy and safety of intra-articular sodium hyaluronate in synovial joints with osteoarthritis. Eur J Phys Rehabil Med
12.
go back to reference Priano F, Guelfi M (2007) Efficacy of intra-articular hyaluronic acid (Hyalubrix®) in arthroscopy. Artroscopia VIII(no. 1):3–12 Priano F, Guelfi M (2007) Efficacy of intra-articular hyaluronic acid (Hyalubrix®) in arthroscopy. Artroscopia VIII(no. 1):3–12
13.
go back to reference Smiderle C, Scapin M, Ronconi L, Baldo M, Villaminar R (2007) Gait analysis of changes in clinical and biomechanical parameters in osteoarthritis knee patients after intra-articular infiltration with hyaluronic acid h.m.w. Eur Med Phys 43(Suppl 1–3):5–17 Smiderle C, Scapin M, Ronconi L, Baldo M, Villaminar R (2007) Gait analysis of changes in clinical and biomechanical parameters in osteoarthritis knee patients after intra-articular infiltration with hyaluronic acid h.m.w. Eur Med Phys 43(Suppl 1–3):5–17
14.
go back to reference Vad VB, Sakalkale D, Sculco TP, Wickiewicz TL (2003) Role of hylan G-F 20 in treatment of osteoarthritis of the hip joint. Arch Phys Med Rehabil 84(8):1224–1226PubMedCrossRef Vad VB, Sakalkale D, Sculco TP, Wickiewicz TL (2003) Role of hylan G-F 20 in treatment of osteoarthritis of the hip joint. Arch Phys Med Rehabil 84(8):1224–1226PubMedCrossRef
15.
go back to reference Caglar-Yagci H, Unsal S, Yagci I et al (2005) Safety and efficacy of ultrasound-guided intra-articular Hylan G-F 20 injection in osteoarthritis of the hip: a pilot study. Rheumatol Int 25(5):341–344PubMedCrossRef Caglar-Yagci H, Unsal S, Yagci I et al (2005) Safety and efficacy of ultrasound-guided intra-articular Hylan G-F 20 injection in osteoarthritis of the hip: a pilot study. Rheumatol Int 25(5):341–344PubMedCrossRef
16.
go back to reference Jackson DW, Evans NA, Thomas BM (2002) Accuracy of needle placement into the intra-articular space of the knee. J Bone Joint Surg Am 84A(9):1522–1527 Jackson DW, Evans NA, Thomas BM (2002) Accuracy of needle placement into the intra-articular space of the knee. J Bone Joint Surg Am 84A(9):1522–1527
17.
go back to reference Migliore A, Tormenta S, Martin Martin LS et al (2005) Open pilot study of ultrasound-guided intra-articular injection of hylan G-F 20 (Synvisc) in the treatment of symptomatic hip osteoarthritis. Clin Rheumatol 24(3):285–289PubMedCrossRef Migliore A, Tormenta S, Martin Martin LS et al (2005) Open pilot study of ultrasound-guided intra-articular injection of hylan G-F 20 (Synvisc) in the treatment of symptomatic hip osteoarthritis. Clin Rheumatol 24(3):285–289PubMedCrossRef
18.
go back to reference Migliore A, Tormenta S, Martin Martin LS et al (2006) The symptomatic effects of intra-articular administration of hylan G-F 20 on osteoarthritis of the hip: clinical data of 6 months follow-up. Clin Rheumatol 25(3):389–393PubMedCrossRef Migliore A, Tormenta S, Martin Martin LS et al (2006) The symptomatic effects of intra-articular administration of hylan G-F 20 on osteoarthritis of the hip: clinical data of 6 months follow-up. Clin Rheumatol 25(3):389–393PubMedCrossRef
19.
go back to reference Qvistgaard E, Kristoffersen H, Terslev L et al (2001) Guidance by ultrasound of intra-articular injections in the knee and hip joints. Osteoarthr Cartil 9(6):512–517PubMedCrossRef Qvistgaard E, Kristoffersen H, Terslev L et al (2001) Guidance by ultrasound of intra-articular injections in the knee and hip joints. Osteoarthr Cartil 9(6):512–517PubMedCrossRef
20.
go back to reference Migliore A, Martin Martin LS, Alimonti A et al (2003) Efficacy and safety of viscosupplementation by ultrasound-guided intra-articular injection in osteoarthritis of the hip. Osteoarthr Cartil 11(4):305–306PubMedCrossRef Migliore A, Martin Martin LS, Alimonti A et al (2003) Efficacy and safety of viscosupplementation by ultrasound-guided intra-articular injection in osteoarthritis of the hip. Osteoarthr Cartil 11(4):305–306PubMedCrossRef
21.
go back to reference Migliore A, Massafra U, Iannessi F, Capuano A, Diaco ML, Mascheroni E, Alimonti A, Granata G, Padalino C, Tormenta S 2006 Efficacy and safety of hyalubrix® administration in hip osteoarthritis: prospective cohort study. Ann Rheum Dis. 65 (Suppl II) Migliore A, Massafra U, Iannessi F, Capuano A, Diaco ML, Mascheroni E, Alimonti A, Granata G, Padalino C, Tormenta S 2006 Efficacy and safety of hyalubrix® administration in hip osteoarthritis: prospective cohort study. Ann Rheum Dis. 65 (Suppl II)
22.
go back to reference Migliore A, Bizzi E, Massafra U, Alimonti A, Martin-Martin S, Tormenta S (2008) 18-months followup after intra-articular administration of hyalubrix® in 344 patients with symptomatic osteoarthritis of the hip. Osteoarthr Cartil 16:118–119 Migliore A, Bizzi E, Massafra U, Alimonti A, Martin-Martin S, Tormenta S (2008) 18-months followup after intra-articular administration of hyalubrix® in 344 patients with symptomatic osteoarthritis of the hip. Osteoarthr Cartil 16:118–119
23.
go back to reference Migliore A, Massafra U, Bizzi E, Vacca F, Martin–Martin S, Granata M, Alimonti A, Tormenta S (2009) Comparative, double-blind, controlled study of intra-articular hyaluronic acid (Hyalubrix) injections versus local anesthetic in osteoarthritis of the hip. Arthritis Res Ther 11(6):R183PubMedCrossRef Migliore A, Massafra U, Bizzi E, Vacca F, Martin–Martin S, Granata M, Alimonti A, Tormenta S (2009) Comparative, double-blind, controlled study of intra-articular hyaluronic acid (Hyalubrix) injections versus local anesthetic in osteoarthritis of the hip. Arthritis Res Ther 11(6):R183PubMedCrossRef
24.
go back to reference Altman R, Alarcon G, Appelrouth D et al (1991) The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hip. Arthritis Rheum 34(5):505–514PubMedCrossRef Altman R, Alarcon G, Appelrouth D et al (1991) The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hip. Arthritis Rheum 34(5):505–514PubMedCrossRef
25.
go back to reference Kellgren JH, Lawrence JS (1957) Radiological assessment of osteo-arthrosis. Ann Rheum Dis 16(4):494–502PubMedCrossRef Kellgren JH, Lawrence JS (1957) Radiological assessment of osteo-arthrosis. Ann Rheum Dis 16(4):494–502PubMedCrossRef
26.
go back to reference Lequesne MG (1997) The algofunctional indices for hip and knee osteoarthritis. J Rheumatol 24(4):779–781PubMed Lequesne MG (1997) The algofunctional indices for hip and knee osteoarthritis. J Rheumatol 24(4):779–781PubMed
27.
go back to reference Tormenta S, Migliore A, Nardis P et al (2004) Ultrasound pattern in a cohort of 170 patients suffering from hip osteoarthritis. Osteoarthr Cartil 12(B):P305 S124 Tormenta S, Migliore A, Nardis P et al (2004) Ultrasound pattern in a cohort of 170 patients suffering from hip osteoarthritis. Osteoarthr Cartil 12(B):P305 S124
28.
go back to reference Straube S, Tramèr MR, Moore RA, Derry S, McQuay HJ (2009) Mortality with upper gastrointestinal bleeding and perforation: effects of time and NSAID use. BMC Gastroenterol 9:41PubMedCrossRef Straube S, Tramèr MR, Moore RA, Derry S, McQuay HJ (2009) Mortality with upper gastrointestinal bleeding and perforation: effects of time and NSAID use. BMC Gastroenterol 9:41PubMedCrossRef
29.
go back to reference Gislason GH, Rasmussen JN, Abildstrom SZ et al (2009) Increased mortality and cardiovascular morbidity associated with use of nonsteroidal anti-inflammatory drugs in chronic heart failure. Arch Intern Med 169:141–149PubMedCrossRef Gislason GH, Rasmussen JN, Abildstrom SZ et al (2009) Increased mortality and cardiovascular morbidity associated with use of nonsteroidal anti-inflammatory drugs in chronic heart failure. Arch Intern Med 169:141–149PubMedCrossRef
30.
go back to reference Moore RA, Philips CJ (1999) Cost of NSAID adverse effects to the UK National Health Service. J Med Econ 2:45–55CrossRef Moore RA, Philips CJ (1999) Cost of NSAID adverse effects to the UK National Health Service. J Med Econ 2:45–55CrossRef
31.
go back to reference Zhang W, Doherty M, Arden N, Bannwarth B, Bijlsma J, Gunther KP, Hauselmann HJ, Herrero-Beaumont G, Jordan K, Kaklamanis P, Leeb B, Lequesne M, Lohmander S, Mazieres B, Martin-Mola E, Pavelka K, Pendleton A, Punzi L, Swoboda B, Varatojo R, Verbruggen G, Zimmermann-Gorska I, Dougados M, EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT) (2005) EULAR evidence based recommendations for the management of hip osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 64(5):669–681PubMedCrossRef Zhang W, Doherty M, Arden N, Bannwarth B, Bijlsma J, Gunther KP, Hauselmann HJ, Herrero-Beaumont G, Jordan K, Kaklamanis P, Leeb B, Lequesne M, Lohmander S, Mazieres B, Martin-Mola E, Pavelka K, Pendleton A, Punzi L, Swoboda B, Varatojo R, Verbruggen G, Zimmermann-Gorska I, Dougados M, EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT) (2005) EULAR evidence based recommendations for the management of hip osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 64(5):669–681PubMedCrossRef
Metadata
Title
Intra-articular injection of hyaluronic acid (MW 1,500–2,000 kDa; HyalOne®) in symptomatic osteoarthritis of the hip: a prospective cohort study
Authors
Migliore Alberto
Massafra Umberto
Bizzi Emanuele
Laganà Bruno
Germano Valentina
Piscitelli Prisco
Granata Mauro
Tormenta Sandro
Publication date
01-12-2011
Publisher
Springer-Verlag
Published in
Archives of Orthopaedic and Trauma Surgery / Issue 12/2011
Print ISSN: 0936-8051
Electronic ISSN: 1434-3916
DOI
https://doi.org/10.1007/s00402-011-1353-y

Other articles of this Issue 12/2011

Archives of Orthopaedic and Trauma Surgery 12/2011 Go to the issue